Losing the fold
A protein holds its shape through many weak forces — hydrogen bonds, charge attractions, the way oily side chains hide from water. Heat, freezing, harsh pH, vigorous shaking, or even an air–water surface can overcome those weak forces and let the chain unravel. This unfolding is called denaturation. The protein is still chemically intact — every atom is present — but the shape is wrong, so the medicine no longer works.
Clumping together
Once a protein partly unfolds, its sticky inner surfaces are exposed, and neighbouring molecules glue together. This is protein aggregation, and it is the single most important degradation route in protein formulation. Aggregates range from tiny invisible pairs up to visible flecks, and crucially they often cannot be undone.
Why do clumps matter so much? Two reasons. First, aggregated protein is no longer the right shape, so potency drops. Second, and more seriously, the immune system treats repetitive clumped protein as a danger signal. Even subvisible particles — too small to see but countable by instruments — can provoke unwanted antibodies against the drug. Regulators therefore set strict limits on particle counts in injectable biologics.
Chemical nicks
Beyond shape loss, the chain itself can suffer chemical degradation. Water can split bonds — hydrolysis — clipping the chain or removing chemical groups. Oxygen and trace metals can drive oxidation of vulnerable residues. These are slow, but over a two-year shelf life they add up, and they explain why protein products carry antioxidants, chelating agents and carefully chosen buffers (covered in the next guide).